Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Outcome Among Adolescents and Young Adults with Acute Myeloid Leukemia at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort

Sumit Gupta, MD, Nancy Baxter, MD PhD, Jason Pole, PhD, Cindy Lau, MPH, Rinku Sutradhar, PhD, Chenthila Nagamuthu, MPH, Paul Nathan, MD

Blood (2019) 134 (Supplement_1): 4749.

https://doi.org/10.1182/blood-2019-130145

Published: 2019

Journal Articles

RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy

Brian J Ball, Meier Hsu, MS, Sean M. Devlin, PhD, Christopher Famulare, MS, Sheng F Cai, MDPhD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Kamal Menghrajani, MD, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Aaron D Goldberg, MDPhD, Martin S. Tallman, MD, Eytan M. Stein, MD

Blood (2019) 134 (Supplement_1): 18.

https://doi.org/10.1182/blood-2019-125319

Published: 2019

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Pharmacoeconomic Analysis of the Real World Treatment of Chronic Myeloid Leukemia in Chronic Phase of a Brazilian Private Institution Considering the Use of Generic Drugs and Eventual Discontinuation of Treatment

Renato Torrescasana Centrone, Marcelo Bellesso, MD, Rodrigo Santucci Silva, MD, Eliseo J. Sekiya, MD, Milton A. F. Aranha, MD, Isabel Bonafe, Daniela Ferreira Dias, MD, Adelson Alves, MD

Blood (2019) 134 (Supplement_1): 5847.

https://doi.org/10.1182/blood-2019-128629

Published: 2019

Journal Articles

The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey

James B. Bussel, MD, Alexandra Kruse, Caroline Kruse, Jody Shy, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Keith R McCrae, MD

Blood (2019) 134 (Supplement_1): 1076.

https://doi.org/10.1182/blood-2019-131351

Published: 2019

Journal Articles

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Cynthia R. Giver, PhD, Pamela A Shaw, PhD, Helen Fletcher, PhD, Deepak Kaushal, PhD, Garcia Pamela, Deborah Omoyege, Gregory Bisson, MD, Tawanda Gumbo, MD, Robert Wallis, MD, Edmund K. Waller, PhDMD, Daniel Kalman, PhD

Blood (2019) 134 (Supplement_1): 1050.

https://doi.org/10.1182/blood-2019-130275

Published: 2019

Journal Articles

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Caleb Ho, MD, Yanming Zhang, MD, Umut Aypar, PhD, Mariko Yabe, MD PhD, Filiz Sen, MD, Maria E Arcila, MD, Ahmet Dogan, MD PhD, Kseniya Petrova-Drus, MD PhD

Blood (2018) 132 (Supplement 1): 3077.

https://doi.org/10.1182/blood-2018-99-115698

Published: 2018

Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD

Blood (2018) 132 (Supplement 1): 291.

https://doi.org/10.1182/blood-2018-99-120005

Published: 2018

Journal Articles

Treatment Patterns and Intensity Differ between Pediatric and Adult Centers in AYA with Hodgkin's Lymphoma but Result in Equivalent Outcomes: A Population-Based Study Using the IMPACT Cohort

Sumit Gupta, MD, Nancy Baxter, MD PhD, Jason Pole, PhD, Chenthila Nagamuthu, MPH, Cindy Lau, MPH, Rinku Sutradhar, PhD, Paul Nathan, MD

Blood (2018) 132 (Supplement 1): 831.

https://doi.org/10.1182/blood-2018-99-117321

Published: 2018

Journal Articles

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Blood (2018) 132 (Supplement 1): 747.

https://doi.org/10.1182/blood-2018-99-119530

Published: 2018

Journal Articles

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Nichola Cooper, MRCP, Alexandra Kruse, Caroline Kruse, Shirley Watson, Mervyn Morgan, James B. Bussel, MD, Waleed Ghanima, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Tom Bailey, Gavin Taylor-Stokes, Miona Stankovic, Andrew Provan

Blood (2018) 132 (Supplement 1): 4804.

https://doi.org/10.1182/blood-2018-99-112858

Published: 2018

Journal Articles

Widening Survival Disparities between AYA with ALL Treated in Pediatric Vs. Adult Centers: A Population-Based Study Using the IMPACT Cohort

Sumit Gupta, MD PhD, Jason Pole, PhD, Cindy Lau, MSc, Chenthila Nagamuthu, MSc, Rinku Sutradhar, PhD, Nancy Baxter, MD PhD, Paul Nathan, MD

Blood (2017) 130 (Supplement 1): 1282.

https://doi.org/10.1182/blood.V130.Suppl_1.1282.1282

Published: 2017

Journal Articles

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

Abhinita S. Mohanty, MS, Juan Camilo Gomez-Gelvez, MD, Kseniya Petrova-Drus, Michael Zaidinski, Wei Wang, Jin Juan Yao, MD PhD, Caleb Ho, MD, Ahmet Zehir, PhD, Maria E. Arcila

Blood (2017) 130 (Supplement 1): 1943.

https://doi.org/10.1182/blood.V130.Suppl_1.1943.1943

Published: 2017

Journal Articles

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Paul Rennert, PhD, Christine Ambrose, PhD, Lihe Su, PhD, Fay Dufort, PhD, Lan Wu, PhD, Andreas Hombach, PhD, Hinrich Abken, PhD, Roy Lobb, PhD

Blood (2017) 130 (Supplement 1): 4457.

https://doi.org/10.1182/blood.V130.Suppl_1.4457.4457

Published: 2017

Journal Articles

Population-Scale Identification of Clonal Hematopoiesis Derived Mutations in Solid Tumor Mutation Profiling

Ryan Ptashkin, MS, Catherine C. Coombs, MD, David M. Hyman, MD, David Solit, MD, Jose Baselga, MD, Maria E. Arcila, Marc Ladanyi, MD, Ross L. Levine, MD, Michael F. Berger, PhD, Ahmet Zehir, PhD

Blood (2017) 130 (Supplement 1): 2418.

https://doi.org/10.1182/blood.V130.Suppl_1.2418.2418

Published: 2017

Journal Articles

External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans

Neela K Kumar, MSPH, Erin R Weeda, PharmD, Philip S Wells, MD, Frank Peacock, MD, Gregory J Fermann, MD, Li Wang, MA, PhD MBA, Onur Baser, MS, PhD, Jeff Schein, DrPH, MPH, Crivera Crivera, PharmD, MPH, Craig I Coleman, PharmD, Christine G Kohn, PharmD

Blood (2016) 128 (22): 533.

https://doi.org/10.1182/blood.V128.22.533.533

Published: 2016

Journal Articles

Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age

Binod Dhakal, MDMS, Ariel Nelson, MD, Guru Subramanian Guru Murthy, MD, Raphael Fraser, PhD, Daniel Eastwood, Mehdi Hamadani, MD, Anita D'Souza, MBBS, MD, Parameswaran Hari, MD MRCP, MS

Blood (2016) 128 (22): 3456.

https://doi.org/10.1182/blood.V128.22.3456.3456

Published: 2016

Journal Articles

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Sumit Middha, PhD, Donavan Cheng, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Mark Ladanyi, MD, Martin S Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2015) 126 (23): 2447.

https://doi.org/10.1182/blood.V126.23.2447.2447

Published: 2015

Journal Articles

Validation of the Inhospital Mortality for Pulmonary Embolism Using Claims Data (IMPACT) Prediction Rule within an All-Payer Inpatient Administrative Claims Database

Craig I Coleman, PharmD, Christine G Kohn, PharmD, Concetta Crivera, Jeff Schein, W Frank Peacock, MD FACEP

Blood (2015) 126 (23): 747.

https://doi.org/10.1182/blood.V126.23.747.747

Published: 2015

Journal Articles

IMPACT of Therapeutic Strategy and Time to Therapy Initiation on Clinical Evolution in Higher-Risk Myelodysplastic Syndromes. a Report from Erasme Study

Julia Montoro, MD, Rosa Coll, MD, David Valcarcel, MD PhD, Mar Tormo, MD, Maria Calbacho, MDPhD, Teresa Bernal, MD, Alfonso Fernandez, Joaquin Sanchez, MD, Manuel Albors, Montserrat Arnan, MD, Edgardo Barranco, Montse Rafel, Regina Garcia, MD

Blood (2014) 124 (21): 1908.

https://doi.org/10.1182/blood.V124.21.1908.1908

Published: 2014

NARROW

Outcome Among Adolescents and Young Adults with Acute Myeloid Leukemia at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort

RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Pharmacoeconomic Analysis of the Real World Treatment of Chronic Myeloid Leukemia in Chronic Phase of a Brazilian Private Institution Considering the Use of Generic Drugs and Eventual Discontinuation of Treatment

The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Treatment Patterns and Intensity Differ between Pediatric and Adult Centers in AYA with Hodgkin's Lymphoma but Result in Equivalent Outcomes: A Population-Based Study Using the IMPACT Cohort

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Widening Survival Disparities between AYA with ALL Treated in Pediatric Vs. Adult Centers: A Population-Based Study Using the IMPACT Cohort

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Population-Scale Identification of Clonal Hematopoiesis Derived Mutations in Solid Tumor Mutation Profiling

External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans

Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Validation of the Inhospital Mortality for Pulmonary Embolism Using Claims Data (IMPACT) Prediction Rule within an All-Payer Inpatient Administrative Claims Database

IMPACT of Therapeutic Strategy and Time to Therapy Initiation on Clinical Evolution in Higher-Risk Myelodysplastic Syndromes. a Report from Erasme Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only